Table Info

Table 1.

Baseline demographic and biochemical profile and severity of CAD patients

Serial number (S. No.)	Demographic variables	Group I	Group II	P value
1	Age (mean ± SD)	54.19 ± 10.15	53.15 ± 10.36	0.504
2	Male	81 (81%)	89 (89%)	0.082
3	Female	19 (19%)	11 (11%)	0.082
4	HbA1c (mean ± SD)	8.83 ± 2.03	5.66 ± 0.38	< 0.001^*
5	RBS (mean ± SD)	220.63 ± 100.26	120.61 ± 42.52	< 0.001^*
6	GS (mean ± SD)	31.98 ± 24.13	30.22 ± 25.53	0.476

^* P < 0.001

Declarations

Author contributions

DS, PKD, and DDS: Conceptualization, Methodology, Formal analysis, Validation, Writing—original draft. PKD: Resources, Data curation. VM: Resources, Data curation, Validation.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

The study is approved by Institutional ethical committee of Maulana Azad Medical College and associated hospitals, Delhi, India (F1/IEC/MAMC/85/03/21/no.422; Dt-30.08.2021) and complies with the Declaration of Helsinki.

Consent to participate

Informed consent to participate in the study was obtained from all participants.

Consent to publication

Not applicable.

Availability of data and materials

Not Applicable.

Funding

Not applicable.

Copyright

References

Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation. 2020;141:e139–596. [DOI] [PubMed]

Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014;5:927–46. [PubMed] [PMC]

Siscovick DS, Sotoodehnia N, Rea TD, Raghunathan TE, Jouven X, Lemaitre RN. Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community. Rev EndocrMetabDisord. 2010;11:53–9. [DOI] [PubMed] [PMC]

Zhang HW, Jin JL, Cao YX, Guo YL, Wu NQ, Zhu CG, et al. Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis. Cardiovasc Diabetol. 2021;20:214. [DOI] [PubMed] [PMC]

Morgan KP, Kapur A, Beatt KJ. Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. Heart. 2004;90:732–8. [DOI] [PubMed] [PMC]

Zemlin AE, Matsha TE, Hassan MS, Erasmus RT. HbA1c of 6.5% to diagnose diabetes mellitus—does it work for us? — the Bellville South Africa study. PLoS One. 2011;6:e22558. [DOI] [PubMed] [PMC]

Page HL Jr. The Judkins technique. Cathet Cardiovasc Diagn. 1979;5:187–9. [DOI] [PubMed]

Lipinski M, Do D, Morise A, Froelicher V. What percent luminal stenosis should be used to define angiographic coronary artery disease for noninvasive test evaluation? Ann Noninvasive Electrocardiol. 2002;7:98–105. [DOI] [PubMed] [PMC]

Vyas P, Meghnathi H, Joshi H, Brahmbhatt J, Dake R, Satpute A, et al. Coexistent coronary artery disease in Indian patients undergoing permanent pacemaker implantation (PPI) for symptomatic bradyarrhythmia. Indian Heart J. 2021;73:577–81. [DOI] [PubMed] [PMC]

10.

Gensini GG. Coronary arteriography: role in myocardial revascularization. Postgrad Med. 1978;63:121–38. [DOI]

11.

Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17:83. [DOI] [PubMed] [PMC]

12.

Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes. 2014;5:444–70. [DOI] [PubMed] [PMC]

13.

Ghazanfari Z, Haghdoost AA, Alizadeh SM, Atapour J, Zolala F. A comparison of HbA1c and fasting blood sugar tests in general population. Int J Prev Med. 2010;1:187–94. [PubMed] [PMC]

14.

Nicholas J, Charlton J, Dregan A, Gulliford MC. Recent HbA1c values and mortality risk in type 2 diabetes. Population-based case-control study. PLoS One. 2013;8:e68008. [DOI] [PubMed] [PMC]

15.

Hegde SS, Mallesh P, Yeli SM, Gadad VM, M GP. Comparitive angiographic profile in diabetic and non-diabetic patients with acute coronary syndrome. J Clin Diagn Res. 2014;8:MC07–10. [DOI] [PubMed] [PMC]

16.

Ezhumalai B, Jayaraman B. Angiographic prevalence and pattern of coronary artery disease in women. Indian Heart J. 2014;66:422–6. [DOI] [PubMed] [PMC]

17.

Dave TH, Wasir HS, Prabhakaran D, Dev V, Das G, Rajani M, et al. Profile of coronary artery disease in Indian women: correlation of clinical, non invasive and coronary angiographic findings. Indian Heart J. 1991;43:25–9. [PubMed]

18.

Wu TG, Wang L. Angiographic characteristics of the coronary artery in patients with type 2 diabetes. Exp Clin Cardiol. 2002;7:199–200. [PubMed] [PMC]

19.

Chu ZG, Yang ZG, Dong ZH, Zhu ZY, Peng LQ, Shao H, et al. Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography. Cardiovasc Diabetol. 2010;9:74. [DOI] [PubMed] [PMC]

20.

Cai A, Li G, Chen J, Li X, Wei X, Li L, et al. Glycated hemoglobin level is significantly associated with the severity of coronary artery disease in non-diabetic adults. Lipids Health Dis. 2014;13:181. [DOI] [PubMed] [PMC]

21.

Nanayakkara, PGCJ, Weerarathna TP, Herath HMM, Kariyawasam AGTA,Ganegoda VR. Value of testing glycated hemoglobin in non-diabetic patients presenting with acute coronary syndrome. SJDEM. 2015;5:4–7. [DOI]